Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The N-methyl-D-aspartate (NMDA) receptor and voltage-gated sodium channels (VGSCs) are distinct classes of ion channels that play fundamental roles in neuronal excitability and synaptic transmission. The NMDA receptor is a glutamate-gated cation channel that mediates the slow component of excitatory synaptic transmission and is crucial for long-term potentiation and memory formation [1: https://www.ncbi.nlm.nih.gov/books/NBK526134/]. Voltage-gated sodium channels are responsible for the rapid upstroke of the action potential, allowing for the propagation of electrical signals along axons [2: https://www.ncbi.nlm.nih.gov/books/NBK540972/]. In various pathological states, such as epilepsy, stroke, and chronic pain, overactivation of these channels leads to neuronal hyperexcitability and excitotoxicity [3: https://pubmed.ncbi.nlm.nih.gov/11511381/]. Pharmacological agents that target both NMDA receptors and VGSCs, such as lamotrigine and riluzole, are used to stabilize neuronal membranes and prevent excessive glutamate release or post-synaptic activation [4: https://pubchem.ncbi.nlm.nih.gov/compound/Lamotrigine, 5: https://pubmed.ncbi.nlm.nih.gov/11511381/]. This dual mechanism is particularly effective in treating refractory seizures and providing neuroprotection, although it requires careful management of side effects like dizziness and cognitive slowing [6: https://pubmed.ncbi.nlm.nih.gov/24552133/].
Dual inhibition of excitatory neurotransmission via NMDA receptor antagonism and stabilization of neuronal membranes through voltage-gated sodium channel blockade.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-methyl-D-aspartate receptor and voltage-gated sodium channels (NMDAR + VGSC).